Why is Indrayani Biotec falling/rising?

As of 22-Jul, Indrayani Biotech Ltd's stock price is currently at 15.75, reflecting a decrease of 0.2, or 1.25%. The stock has experienced a trend reversal, falling after four consecutive days of gains. Despite this recent decline, the stock has shown a strong performance over the past week and month, with returns of 12.90% and 11.86%, respectively. However, it has generated a significant loss of 70.00% over the past year, and its profits have sharply declined by 134.9%. The company is facing challenges, including operating losses and a high Debt to EBITDA ratio of 9.25 times, which indicates a weak long-term fundamental strength. Additionally, institutional investors have reduced their stake in the company, suggesting a lack of confidence in its future performance. In the broader market context, while Indrayani Biotech's recent short-term performance has outpaced the Sensex, which has seen a slight decline of 0.47% over the past week, the stock's long-term performance remains concerning. The company has underperformed the BSE500 over the last three years, one year, and three months, indicating a persistent struggle in the market. The overall negative sentiment surrounding the stock, compounded by its substantial losses and declining institutional interest, contributes to its current price movement.